Biotechnology as applied to food and plants has been overlooked by the leading countries in this sector – the United States, Canada, the United Kingdom and the Nordic countries.
For this reason, "Spanish biotechnology should focus on these two fields of specialisation, since it is a growing business sector and a market niche in which Spain could be competitive", Isidre March-Chorda, lead author of the study and a researcher at the Department of Business Management in the Faculty of Economics at the UV, tells SINC.
The purpose of this research, which has been published in the latest edition of the journal Technology Analysis & Strategic Management, was to carry out a detailed study of the behaviour of Spanish biotechnology companies from 2004 to 2005.
The researchers created a database using information from the Spanish Genome Foundation and the ASEBIO Foundation, and identified 102 companies and their economic-financial data and a series of factors to analyse for the study.
According to the study, there are two business models. On one side is the long haul model, or the 'biotechnology of discovery model', which is most important internationally and is the leader in the countries which have been pioneers in this industry (the United States and Canada).
"These companies spend 10 or 15 years developing a new drug. At the end of this time they can sell it to a multinational pharmaceutical firm and recover their investment. They make a discovery that has a major impact on the market", explains March-Chorda.
On the other side is the incremental innovation, service-oriented model, which involves lower levels of innovation and risk. It is used by companies that provide diagnosis services and equipment for the medical, surgical and clinical sectors, and is an environment where there is more competition and less differentiation.
Of all the companies analysed, only 16 had the same kind of characteristics as the predominant model in the English-speaking world (15.7% of the whole sample), showing that very few companies in Spain are driven by invention or discovery.
Since 2001, however, biotechnology businesses that operate along the lines of the first business model have been set up in Spain in the field of human health and the search for new biopharmaceutical treatments.
The funding problem
Spain will have to overcome a hurdle in the next few years – the high cost of developing and commercialising new medicines, which the study says stands at around €700 million.
"In Spain we lack the kind of financing system to fund this kind of initiative, in which the risks are high and the development period is very long. This is not the case in the English-speaking world, though, where they have stock exchanges that accept biotech companies and the whole risk capital industry is more more developed", explains the economist.
The problem is that, because less is spent here on R&D, the products developed are less novel, and their market impact is lower, meaning companies have only limited possibilities for growth. March-Chorda says this could be why Spanish biotech companies have not seen their market value take off within a short period of time "as has happened in the English-speaking world".
He concludes: "If large Spanish companies were prepared to invest in this sector, it is likely that more biotechnology companies would be set up along the same lines as the model used in the English-speaking world".
March-Chorda, Isidre, Yague-Perales, Rosa M, Seoane-Trigo, Ramón. "Asymmetric behaviour of biotechnology business patterns in Spain". Technology analysis & strategic management 21 (6): 765-782, 2009.
SINC | EurekAlert!
New photocatalyst speeds up the conversion of carbon dioxide into chemical resources
29.05.2017 | DGIST (Daegu Gyeongbuk Institute of Science and Technology)
Copper hydroxide nanoparticles provide protection against toxic oxygen radicals in cigarette smoke
29.05.2017 | Johannes Gutenberg-Universität Mainz
The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.
The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
29.05.2017 | Earth Sciences
29.05.2017 | Life Sciences
29.05.2017 | Physics and Astronomy